MyFinsight
Home
Blog
About
Net income
$54,768K
(-26.06%↓ Y/Y)
Stock-based compensation
expense, net
$14,156K
(-48.70%↓ Y/Y)
Accrued rebates
$13,149K
(-11.36%↓ Y/Y)
Proceeds from exercise of
stock options
$15,161K
(365.35%↑ Y/Y)
Accrued expenses and
other current...
$5,438K
(126.49%↑ Y/Y)
Accounts payable
$3,057K
(-39.21%↓ Y/Y)
Other long-term
liabilities
$2,027K
(48.17%↑ Y/Y)
Depreciation
$1,356K
(-50.85%↓ Y/Y)
Amortization of operating
lease right-of-use...
$210K
(-49.76%↓ Y/Y)
Other, net
$174K
(-74.78%↓ Y/Y)
Net cash provided by
operating activities
$74,789K
(-10.64%↓ Y/Y)
Net cash provided by
(used in) financing...
$15,053K
(241.08%↑ Y/Y)
Canceled cashflow
$20,122K
Canceled cashflow
$108K
Net (decrease)
increase in cash and cash...
-$73,573K
(-920.76%↓ Y/Y)
Canceled cashflow
$89,842K
Maturities of investments
$100,004K
(-48.47%↓ Y/Y)
Accounts receivable, net
$11,973K
(78.89%↑ Y/Y)
Prepaid taxes
$4,667K
(accretion) amortization on
marketable securities
$1,324K
Inventory
$958K
(86.02%↑ Y/Y)
Realized gain on
investments
$748K
(-82.42%↓ Y/Y)
Lease liability
-$259K
(-0.39%↓ Y/Y)
Prepaid expenses and
other current assets
$193K
(-93.47%↓ Y/Y)
Taxes paid for
employee tax withholding...
$108K
(-99.11%↓ Y/Y)
Net cash (used in)
investing activities
-$161,584K
(-147.47%↓ Y/Y)
Canceled cashflow
$100,004K
Effect of exchange rate
changes on cash and cash...
-$1,831K
(-248.86%↓ Y/Y)
Purchases of investments
$258,023K
(2.51%↑ Y/Y)
Purchases of property and
equipment
$3,565K
(-56.03%↓ Y/Y)
Back
Back
Cash Flow
Krystal Biotech, Inc. (KRYS)
Krystal Biotech, Inc. (KRYS)
source: myfinsight.com